Featured Research

from universities, journals, and other organizations

Lower detection of prostate cancer with PSA screening in US than in a European randomized trial

Date:
February 8, 2010
Source:
Journal of the National Cancer Institute
Summary:
Fewer prostate cancers were detected by prostate-specific antigen (PSA) screening in the US than in a European randomized trial because of lower screening sensitivity, according to a new study.

Fewer prostate cancers were detected by prostate-specific antigen (PSA) screening in the U.S. than in a European randomized trial because of lower screening sensitivity, according to a new brief communication published online February 8 in the Journal of the National Cancer Institute.

To compare the PSA screening performance in a clinical trial with that in a population setting, Elisabeth M. Wever, MSc, Department of Public Health, Erasmus Medical Center, the Netherlands, and colleagues applied a microsimulation model developed for prostate cancer and screening to the European Randomized Study of Screening for Prostate Cancer (ERSPC)-Rotterdam. The model was adapted by replacing the trial's demography parameters with U.S.-specific ones and the screening protocol with the frequency of PSA tests in the population. The natural progression of prostate cancer and the sensitivity (percentage of men correctly identified as having prostate cancer of those who have preclinical prostate cancer) of a PSA test followed by a biopsy were assumed to be the same in the US as in the trial.

The prostate cancer incidence predicted by the model in the U.S. was substantially higher than the actual prostate cancer incidence. However, the actual incidence was reproduced by assuming a substantially lower PSA test sensitivity in the U.S. than in ERSPC-Rotterdam.

The authors concluded that the efficacy of PSA screening in the U.S. was lower than in ERSPC-Rotterdam because of the lower sensitivity of PSA testing followed by biopsy. The estimates of PSA test sensitivity were 0.26 in the U.S. versus 0.94 in ERSPC-Rotterdam.

In an accompanying editorial, Peter C. Albertsen, M.D., of the University of Connecticut Health Center, in Farmington, calls the study's findings remarkable and instructive. If the U.S. ever wanted to match the trial's results, he writes, the inten¬sity of PSA screening and prostate biopsy would need to increase by well more than 50% from the values recorded in 1992, a time when incidence rates were at their peak.

Also, the rates of radical prostatectomy and radiation therapy among men aged 55-69 years would need to increase by 50% to achieve the mortality reduction noted in the ERSPC trial. "The consequences of such large increases in surgery and radiation are sobering," he writes.


Story Source:

The above story is based on materials provided by Journal of the National Cancer Institute. Note: Materials may be edited for content and length.


Cite This Page:

Journal of the National Cancer Institute. "Lower detection of prostate cancer with PSA screening in US than in a European randomized trial." ScienceDaily. ScienceDaily, 8 February 2010. <www.sciencedaily.com/releases/2010/02/100208185208.htm>.
Journal of the National Cancer Institute. (2010, February 8). Lower detection of prostate cancer with PSA screening in US than in a European randomized trial. ScienceDaily. Retrieved September 20, 2014 from www.sciencedaily.com/releases/2010/02/100208185208.htm
Journal of the National Cancer Institute. "Lower detection of prostate cancer with PSA screening in US than in a European randomized trial." ScienceDaily. www.sciencedaily.com/releases/2010/02/100208185208.htm (accessed September 20, 2014).

Share This



More Health & Medicine News

Saturday, September 20, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Could Grief Affect The Immune Systems Of Senior Citizens?

Could Grief Affect The Immune Systems Of Senior Citizens?

Newsy (Sep. 19, 2014) — The study found elderly people are much more likely to become susceptible to infection than younger adults going though a similar situation. Video provided by Newsy
Powered by NewsLook.com
Jury Delivers Verdict in Salmonella Trial

Jury Delivers Verdict in Salmonella Trial

AP (Sep. 19, 2014) — A federal jury has convicted three people in connection with an outbreak of salmonella poisoning five years ago that sickened hundreds of people and was linked to a number of deaths. (Sept. 19) Video provided by AP
Powered by NewsLook.com
How The 'Angelina Jolie Effect' Increased Cancer Screenings

How The 'Angelina Jolie Effect' Increased Cancer Screenings

Newsy (Sep. 19, 2014) — Angelina's Jolie's decision to undergo a preventative mastectomy in 2013 inspired many women to seek early screenings for the disease. Video provided by Newsy
Powered by NewsLook.com
The Cost of Ebola

The Cost of Ebola

Reuters - Business Video Online (Sep. 18, 2014) — As Sierra Leone prepares for a three-day "lockdown" in its latest bid to stem the spread of Ebola, Ciara Lee looks at the financial implications of fighting the largest ever outbreak of the disease. Video provided by Reuters
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
 
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:  

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:  

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile iPhone Android Web
Follow Facebook Twitter Google+
Subscribe RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins